No description available.

Die Wespengiftallergie stellt eine typische allergische Sofortreaktion dar. Für diese IgE-vermittelten, pathologischen Immunreaktionen ist die spezifische Immuntherapie (IT) die einzige zur Zeit zur Verfügung stehende kausale Therapie. Die Wirkmechanismen sind trotz intensiver Bemühungen weiterhin nicht vollständig aufgeklärt. Als wichtigste These wird zur Zeit eine Verlagerung des pathologischen, TH2-dominierten Zytokinmilieus in Richtung "normales" TH1-Milieu diskutiert. Es wurde auch eine reduzierte Mediatorfreisetzung von Effektorzellen, eine verminderte Leukozytenproliferation, eine verminderte Endorganantwort und charakteristische Ig-Titer-Veränderungen mit initialem Anstieg und längerfristigem Abfall des sIgE und Anstieg des sIgG4 beschrieben. In der vorliegenden Arbeit wurde der Einfluß der IT auf periphere B-Zellen hinsichtlich ihrer Ig-Produktion und ihres Phänotyps untersucht. 15 Patienten mit systemischen Reaktionen nach Wespenstich, Nachweis von spezifischem IgE und positivem Hauttest, bei denen eine Schnell-Immuntherapie eingeleitet wurde, wurden vor Beginn der Therapie (Tag 1), am Tag ihrer Entlassung (Tag 6), also einen Tag, nachdem die Erhaltungsdosis von 100 µg erreicht wurde, und vor der 2. ambulanten Allergeninjektion am 26. Tag untersucht. Die Expression von CD5, CD23, CD32, CD40, CD54, CD86, CD95, HLA-I-ABC und HLA-II-DR wurde auf peripheren mononukleären Blutzellen durchflußzytometrisch bestimmt. Anti-CD19 FITC wurde als spezifischer B-Zellmarker benutzt. Die Serum-Titer des Gesamt-IgE, Wespengift-spezifischen IgE und Wespengift-spezifischen IgG4 wurden mittels ELISA bestimmt. Zur statistischen Auswertung wurde der Wilcoxontest für nicht-parametrische, verbundene Daten benutzt. Die Expression von CD54, CD5, CD32 und HLA-II-DR wurde durch die IT signifikant und die von CD23 tendentiell modifiziert. So war die Expression dieser Moleküle auf der Oberfläche peripherer B-Zellen am Tag 6 im Vergleich zum Ausgangswert vom Tag 1 reduziert. Am 26. Tag wurden wieder Werte auf der Höhe der Ausgangswerte vom Tag 1 gemessen. Dagegen veränderte sich die Expression von CD40, CD86, CD95 und HLA-I-ABC während der untersuchten Zeitpunkte nicht. Die Ig-Titer veränderten sich in der für die IT charakteristischen Weise. So stieg nach 3 Wochen der Gesamt-IgE-, sIgE- und sIgG4-Titer hochsignifikant an. Die Expression der untersuchten Oberflächenmoleküle ist als Indikator für Veränderungen der Aktivationslage und des funktionellen Status der Zellen während der IT zu interpretieren. So spricht die Reduktion der Expression von CD32, CD54 und HLA-II für eine verminderte Aktivierungslage der peripheren B-Zellen. Ferner deutet die Reduktion von CD5 und CD32 auf eine Anergie der B-Zellen hin. Durch die reduzierte Expression von CD23 und CD54 könnte die T-B-Zell-Interaktion verschlechtert werden, die für die Effektorfunktionen beider Zellen bedeutsam ist.Einen wesentlichen Beitrag zur Wirksamkeit der IT könnte auch die verminderte Expression des HLA-II leisten, da HLA-II für die Ag-Präsentation essentiell ist. In dieser Arbeit wurde gezeigt, daß die spezifische Immuntherapie einen Einfluß nicht nur auf die Ig-Produktion der B-Zellen hat, sondern auch auf deren Phänotyp. Dies könnte Hinweise auf bisher nicht bekannte Mechanismen bieten, die an der Wirksamkeit der IT beteiligt sind. / Wasp-venom allergy is a typical IgE-mediated allergic reaction. Specific immunotherapy (IT) is the only currently available causal therapy for IgE-mediated allergies. The mechanisms responsible for the efficacy of IT are still not fully understood. So far, the main focus of research has been on changes of T-helper cell (TH) cytokine production with a shift from TH2 to TH1 cytokines. Reduced mediator secretion from effector cells of allergic reactions, decreased leukocyte proliferation, lowered responsiveness of end organs and changes in immunoglobulin levels have been reported as well. The purpose of this study was to investigate the influence of IT on phenotype and Ig-production of B-lymphocytes. 15 venom allergic patients with a history of systemic reactions after a wasp sting and venom-specific skin test reactivity as well as serum IgE were investigated before VIT (day 1), one day after reaching maintenance dose of 100 µg (day 6) during inpatient rush VIT, and again on day 26 during continued outpatient maintenance therapy. Changes in the serum levels of total IgE, allergen-specific IgE (sIgE) and sIgG4 were measured by ELISA. Expression of CD5, CD23, CD32, CD40, CD54, CD86, CD95, HLA-I-ABC and HLA-II-DR on double labeled B cells was studied by flow cytometry of peripheral blood mononuclear cells. On day 6, cell surface expression of CD54, CD5, CD32 and HLA-II-DR was decreased significantly in intensity and numbers of positive cells, compared to day 1, while on day 26, expression of these molecules approached again baseline levels. Furthermore, a trend to decreased CD23 was noted on day 6. No changes were observed for CD40, CD86, CD95 and HLA-I-ABC. Levels of total IgE, sIgE and sIgG4 showed a significant increase after 26 days of VIT. These data show that initiation of rush VIT has profound effects on B-cell phenotype and Ig-production. Reduced expression of surface molecules can be interpreted as a reduction of activation status of B-cells as well as reduced ability to present antigen and to costimulate other leukocytes. B cells may thus be additional direct or indirect targets of high dose antigen therapy and contribute to the efficacy of IT.

Thesis (M.Tech.: Homoeopathy)-Dept of Homoeopathy, Durban Institute of Technology, 2004 xiv, 154 leaves : ill. ; 30 cm / This study was conducted by administering Naja mossambica 30CH (a homoeopathic remedy derived from the venom of the Mozambican spitting cobra) to healthy individuals in order to elicit and document the resulting mental and physical symptomology. These symptoms were compared to the toxicology of Naja mossambica venom as well as a doctrine of signatures analysis of the snake in order to expand and clarify the remedy picture. Existing knowledge of the venom toxicology gives a clear indication of the organs and body systems that the substance has an affinity for. Many poisonous substances used homoeopathically rely heavily on inferences made from the toxicology of the substance, as much of the gross pathology in the symptom picture cannot safely be elucidated in a proving. The aim of this study was to determine the sphere of action of Naja mossambica by utilising symptoms obtained from the proving and from the toxicology of the venom. This was done in order to determine the remedy's usefulness in a homoeopathic clinical setting by expanding our understanding of the substance and thereby facilitating the treatment of disease based on the law of similars.

Submitted in partial compliance with the requirements of the Master’s Degree in Technology: Homoeopathy, Durban University of Technology, 2013. / Introduction The aim of this study was to investigate the homeopathic potential of Bitis atropos 30CH (Homoeopathically prepared Berg adder venom) and to compare the materia medica of Bitis atropos with that of existing remedies originating from remedies derived from the same genus: Bitis. It was hypothesised that the thirtieth centesimal potency of the substance Bitis atropos would produce clearly observable signs and symptoms in healthy volunteers, furthermore it was hypothesised that the materia medica of Bitis atropos would be comparable with those of existing remedies originating from the genus Bitis. Methodology The homeopathic drug proving of the substance Bitis atropos 30CH took the form of a double-blinded, randomised, placebo controlled trial. A total of 28 provers took part in the proving, twenty one percent (6 provers) were randomly administered placebo, the other seventy nine percent (22 provers) were randomly administered verum (active proving drug). Each prover received six lactose powder sachets, either placebo or verum, and were instructed to take one powder three times a day or until symptoms arose. Symptoms induced in healthy provers by Bitis atropos or placebo were recorded in journal format on a daily basis for a period of 4 weeks or until symptoms subsided. This data was subsequently transcribed into nomenclature suitable for the materia medica and repertory. A general picture of the remedy was described which according to the Law of Similars forms the clinical indications of the substance in homoeopathic practice. A concurrent study of the proving of Bitis atropos 30CH was conducted by Brijnath (2013), and focused on comparing the results of the proving with the venom toxicology of the snake and other related remedies. Results A wide variety of mental, emotional and physical symptoms were produced. Some of the main themes included feelings of antagonism with one’s self, polarity, anxiety, irritability and a lack of focus with a feeling of confusion. Some of the physical symptoms produced were a lack of energy, fatigue, temperature sensitivity, skin eruptions, eye symptoms, ear symptoms, back pain, asthma symptoms, and an increase in libido. The symptoms from the proving of Bitis atropos 30CH were subsequently compared with remedies that belong to the same genus: Bitis. This analysis aimed to demonstrate the similarities between the remedies in the same genus: Bitis. A significant degree of similarity was noted within the mental sphere, where the remedies shared the same themes of anxiety, irritability, polarity, confusion and lack of mental focus. Some of the physical symptoms shared by the remedies were those of respiratory symptoms, temperature sensitivity, fatigue, lack of energy and headaches and an increased libido. Conclusion This investigation supported the hypothesis that Bitis atropos 30CH would produce clear and observable signs and symptoms in healthy volunteers in addition it supported the hypotheses that the materia medica produced would be comparable to the existing remedies sharing the same genus i.e.- Bitis arietans arietans(Puff adder) and Bitis gabonica gabonica (Gaboon viper).

Class of 2012 Abstract / Specific Aims: Determine the difference in venom potency among Mohave Rattlesnakes in Cochise in Pima Counties and determine if those differences correlate to changes in clinical outcomes. Methods: Twenty-one Mohave rattlesnakes, C. s. scutulatus were collected from Arizona and New Mexico. Venom proteomes were analyzed using RP-HPLC and SDS-PAGE. The toxicity of venoms was analyzed using LD50. Health severity outcomes between two Arizona counties, Pima and Cochise, were determined by retrospective chart review of the Arizona Poison and Drug Information Center database between 2002-2009. Main Results: Six phenotypes were identified based on three venom proteins; Mojave toxin, SVMP PI and PIII, and myotoxin. Venom changed geographically from SVMP-rich to Mojave toxin-rich phenotypes from south central to southeastern Arizona. Phenotypes containing myotoxins were only found in the transitional zone between the SVMP and Mojave toxin phenotypes. Venom samples containing the largest amounts of SVMP or Mojave toxin had highest and lowest LD50s, respectively. Conclusions: There was a significant difference when comparing the presence of CNS affects between Pima and Cochise counties (p = 0.001). No significant difference was found when comparing severity number of antivenom vials administered, days spent in a health care facility or envenomation per 100,000 population. Although not part of the original data to be collected, death and intubations, were also noted. There is a 10x and 50x increased risk of death or intubations if envenomated in Cochise County.

Les Hyménoptères parasitoïdes ont un développement larvaire s'effectuant au détriment d'un organisme hôte. Pour exploiter au mieux la ressource que représente un hôte arthropode dont la biologie peut présenter certains obstacles tels que la mobilité et le système immunitaire, les parasitoïdes ont développé une diversité modes de vie et de stratégies de virulence. Ce manuscrit replace les parasitoïdes dans leur contexte évolutif afin de mieux comprendre la diversité surprenante de leurs modes de vie. Ces modes de vie conditionnent la nature des interactions dans les systèmes hôte/parasitoïde. Nous verrons comment, par l'utilisation de nombreux facteurs de virulence tel que le venin, les polydnavirus et bien d'autres encore, les parasitoïdes manipulent la physiologie de leur hôte afin de le rendre adéquat à leur propre développement. Ce travail s'est intéressé au modèle endoparasitoïde Hyposoter didymator (Hym., Ichneumonidae). Nous avons ainsi caractérisé les protéines produites dans la glande à venin des femelles et identifié l'ensemble des gènes du polydnavirus associé (HdIV; H. didymator Ichnovirus), grâce à des techniques de protéomique, génomique et transcriptomique. Nous avons également suivi et quantifié les altérations de la physiologie de l'hôte Spodoptera frugiperda au cours du parasitisme et évalué le rôle relatif de différents facteurs dans ces perturbations et dans la réussite parasitaire. Nos résultats ont permis de montrer que seul le fluide du calice contenant HdIV est nécessaire au développement du parasitoïde. En parallèle, nous avons mis à jour une propriété immuno-évasive des œufs d'H. didymator liée à des protéines associées à l'exochorion. L'ensemble de ce travail a permis de dessiner un élégant schéma expliquant la complémentarité spatio-temporelle des facteurs de virulence durant le parasitisme. Finalement, nous avons cherché à mieux comprendre le déterminisme du spectre d'hôte d'H. didymator, ce qui nous a conduit à montrer que les deux stratégies de contournement de la réponse immunitaire (immuno-évasion et infection virale) se révèlent inefficaces chez les hôtes non-permissifs. / Parasitic wasps must deal with physiological features of their host such as mobility, an efficient immune system and a variable metabolism. To ensure successful parasitism in a large range of arthropod hosts, parasitoids display a huge diversity of lifestyle and rely in a variety of virulence factors. In this document, we introduce parasitoid lifestyle in an evolutionary context in order to better understand the parasitoid complexity. As the parasitoid lifestyle drives the host/parasitoid interaction outcome, we discuss for all how the virulence factors such as venom, polydnaviruses and many others are used to ensure successful development of the parasitoid. In this study, we focused on the endoparasitoid Hyposoter didymator (Hym., Ichneumonidae) virulence factors. We thus identified venom proteins and the genes from the associated polydnavirus, HdIV using proteomics, genomics and transcriptomics approaches. Studies on the effect of the venom and the calyx fluid containing the polydnavirus HdIV, reveal that only the calyx fluid is necessary for Spodoptera frugiperda host physiological alteration and parasitism success. Futhermore, this work presents the discovery of a local immune-evasive property of the H. didymator egg exochorion. All these data permitted us to design an effective spatio-temporal model of the virulence factor complementarity used by H. didymator during the parasitism time course. Finally, studies on the H. didymator host range reveals the inefficiency of the different virulence factors in non-permissive hosts, opening insights on the host permissiveness molecular mechanisms.

Les venins animaux, par leur richesse biochimique et la diversité de leurs cibles moléculaires, sont une source importante de molécules dont les applications potentielles sont nombreuses. La recherche de nouveaux médicaments pour remplacer certains antibiotiques devenus inefficaces face à l'apparition de résistances, est un axe fort de la recherche pharmacologique. Depuis plus de 40 ans, la découverte de toxines animales montre que les animaux venimeux peuvent être les « pharmaciens du futur ». Le venin de fourmis est encore peu étudié. Seul celui de quelques espèces a été exploré, avec à chaque fois la mise en évidence de toxines originales. L'objectif de cette thèse a été l'étude du venin de fourmis exotiques sur la base d'une approche pluridisciplinaire qui combine l'analyse biochimique et la toxinologie. Les travaux se sont articulés autour de deux axes principaux : (1) Recherche d'activités biologiques sur insectes et bactéries ; (2) Fractionnement des venins par des techniques séparatives et analyse biochimique des peptides isolés par spectrométrie de masse. Deux espèces de fourmis ont été choisies en fonction de leur mode de vie : Crematogaster striatula, une espèce arboricole et Tetramorium bicarinatum, une espèce terricole. Les différentes activités biologiques de leurs sécrétions venimeuses ont été conduites par test MTT. Le liquide de Dufour de C. striatula en plus de sa capacité à éloigner les espèces concurrentes montre une capacité à paralyser les termites de manière irréversible. Concernant le venin de T. bicarinatum, deux peptides ont été isolés et identifiés par spectrométrie de masse. La bicarinaline, peptide de 20 acides aminés et amidé à son extrémité C-terminale, s'est démarqué par son action antibactérienne à large spectre. Testée sur deux souches de staphylocoques, ce peptide se révèle aussi efficace voire plus puissant que la méllitine, peptide antimicrobien du venin d'abeille. La bicarinaline apparaît comme un candidat potentiel pour la conception de nouveaux traitements antibiotiques. / Animal venoms, by their biochemical richness and diversity of molecular targets, are a highly significant source of new molecules, with numerous potential applications. A major thrust of present pharmacological research now concerns drugs to replace certain antibiotics, proven ineffective due to the appearance of resistant strains. And discoveries of animal toxins over the past 40 years or more, have shown that venomous species could be the « pharmacists of the future », with only a few species of ants' venoms having been studied, but each time resulting in the description of original toxins. The aim of this thesis has been to study the venom of tropical ants using a multidisciplinary approach combining biochemical analysis and toxinology, centred on two main areas: (1) Research into their biological activity on insects and bacteria; (2) Fractionation of venoms using separative techniques, plus biochemical analysis of the peptides isolated using mass spectrometry. Two species of ant have been chosen based on their lifestyles: Crematogaster striatula is arboricolous and Tetramorium bicarinatum, terricolous, and the different biological activities of their crude venoms have been investigated using the MTT test. The Dufour liquid of C. striatula, in addition to its ability to scare away competitors, can definitively paralyse termites. For the venom of T. bicarinatum, two peptides have been isolated, and identified using mass spectrometry. Bicarinalin, a short 20 amino acid residues C-terminally amidated peptide, was notable for its wide spectrum antibacterial activity which, when tested on two Staphylococcus strains, proved to be at least if not more potent than mellitin, the antimicrobial peptide from bee venom. Bicarinalin would thus appear to be a good candidate for the development of new antibiotic drugs.

Os venenos de serpentes peçonhentas representam uma mistura muito rica em compostos orgânicos e inorgânicos com potencial farmacológico, clínico e médico considerável. (As propriedades de seus componentes vêm sendo pesquisadas e características que antes não eram observáveis passam a ser descobertas influenciando à obtenção de novas drogas e na otimização de terapias já existentes. A maior parte dos compostos presentes nos venenos das serpentes é formada por proteínas que representam de 90 a 95% do peso seco do veneno, dentre elas destacam-se as peptidases (serino e metalopeptidases). As serinopeptidases caracterizam-se por apresentar no sítio ativo uma tríade catalítica idêntica a presente na tripsina, a qual é formada pelo agrupamento dos aminoácidos, His 57, Asp 102 e Ser 195. Constituem um grupo de enzimas que apresentam uma ampla variedade de efeitos biológicos, com massa molecular entre 25 kDa e 35 kDa, promovendo diversos efeitos fisiológicos como, alterações no sistema hemostático, agindo nos componentes da cascata de coagulação e com ação fibrinogenolítica. Ainda que já existam enzimas de veneno de serpentes com aplicação na regulação da cascata da coagulação, vários laboratórios têm buscado novas alternativas que apresentem atividade na hemostasia a fim de obtenção de produtos farmacológicos ainda não investigados. As serpentes australianas da família Elapidae, destacam-se para este fim, por apresentarem proteínas pró-coagulantes e até o momento não há descrição na literatura sobre a presença de serinopeptidases no veneno de Pseudechis australis. Neste trabalho conseguimos isolar e confirmar pela primeira vez a presença de uma serinopeptidase do veneno de Pseudechis australis através de técnicas cromatográficas e bioquímicas. Esta serinopeptidase possui atividade sobre a cadeia beta e alfa do fibrinogênio, não possui atividade gelatinolítica e possui semelhanças com o Fator X (FX) da cascata de coagulação. / Snake venoms represent a very rich mixture of organic and inorganic compounds with potential pharmacological, clinical and medical applications. This potential has not been fully exploited due to our incomplete knowledge of the properties of venoms and their components. Most of the compounds present in snake venoms are proteins that represent 90 to 95% of the dry weight, among which stand out peptidases (serine and metallopeptidases). The serinopeptidases are characterized by having a catalytic triad similar to the one present in trypsin, which is formed by, His 57, Asp 102 and Ser 195.These proteins constitute a group of enzymes that have a variety of activities, molecular mass between 25 kDa to 35 kDa, promoting many physiological effects as changes in the hemostatic system, acting on components of the clotting cascade and fibrinogenolytic action. Several snake venoms isolated peptidases are used for therapeutic purposes, among which serinopeptidases as Batroxobin® and Ancrod® used as anticoagulants in heart surgery. Pseudechis australis (King Brown or Mulga Snake) is a terrestrial species among the most poisonous of Australia and belonging to the family Elapidae which constitutes 57.7% of the snake species described in the Australian continent, Australian Elapidae are among the ten more toxic species in the world. Although there are already venom enzymes snakes with application in coagulopathies, several laboratories have sought alternatives for the treatment of hemostasic disorders in order to obtain new pharmacological products. Australian snakes from the Elapidae family, stand out for this purpose, because they have procoagulant proteins with properties similar to the macromolecular complex found in blood. It is worth noting that so far there is no description in the literature on the presence of serinopeptidases in Pseudechis australis venom and since serinopeptidases are closely linked to the hemostatic system, new serinopeptidases may have great potential in the development of drugs for the therapy of hemostatic disorders. In this work we managed to isolate and confirm the first time a serinopeptidase the Pseudechis australis venom through chromatographic and biochemical techniques. This serinopeptidase have activity on alpha and beta chain of fibrinogen, has no gelatinolytic activity and has similarities to factor X of the clotting cascade.

A cada dia os relatos sobre acidentes por escorpiões vêm aumentando no Brasil, com frequentes casos fatais. Dentre os escorpiões que compõem a fauna brasileira temos o Tityus serrulatus, considerado o mais perigoso por conta de sua facilidade adaptativa em centros urbanos e das manifestações clínicas severas em vítimas acidentadas, como febre, agitação psicomotora, hipertensão arterial seguida de hipotensão e edema pulmonar agudo. Dentre os componentes da peçonha se destacam os peptídeos estruturados por ligações dissulfeto, que são abundantemente relatados na literatura e atuam em canais de Na+ e K+. Ao contrário, os peptídeos lineares são pouco caracterizados. A partir desta premissa, nosso grupo identificou peptídeos lineares do veneno através de um screening empregando a enzima elastase. Esta enzima foi escolhida por estar envolvida em processos inflamatórios exacerbados, como em casos de edema pulmonar agudo, que é um dos principais sintomas do escorpionismo. Encontramos mais de 700 sequências peptídicas onde, através de um criterioso processo com o uso de bancos de dados de sequências depositadas e a literatura, selecionamos nove moléculas inéditas (TsP1 a TsP9) e duas já estudadas (hipotensinas I e II) para a síntese. Dentre estas moléculas, identificamos possíveis criptídeos advindos da Ts19 e moléculas com processamento diferenciado envolvendo a combinação de sequências peptídicas diferentes (peptídeos quiméricos), primeiramente relatadas e investigadas na peçonha do T. serrulatus neste trabalho. Além da elastase, utilizamos as enzimas de importância médica tripsina, ECA e NEP e os peptídeos sintéticos em nossos estudos, visando aumentar o conhecimento dos mecanismos moleculares envolvidos no escorpionismo e, também, com base no potencial biotecnológico de moléculas capazes de exercerem modulações das atividades destas peptidases. Destacaram-se peptídeos que podem ter ação em processos inflamatórios, uma vez que foram capazes de aumentar a atividade da elastase e tripsina, com destaque para o TsP5, que também apresentou citotoxidade intermediária. Alguns peptídeos aumentaram a atividade da ECA, sendo o peptídeo TsP2 capaz de potencializar a ação da bradicinina in vivo. A hipotensina I foi caracterizada como um inibidor não competitivo da NEP (Ki = 4,35 µM), podendo indicar a possível inibição desta metalopeptidase nos casos de hipotensão, onde a hipotensina I pode agir de forma sinérgica com o [des-Arg1]-Proctolin (Ki = 0,94 µM para a NEP), outro peptídeo linear do veneno caracterizado por nosso grupo. Os peptídeos não foram reconhecidos pelos soros antiescorpiônico e antiaracnídico produzidos pelo Instituto Butantan podendo indicar limitações na imunoterapia utilizada no tratamento das vítimas. Por fim, além dos novos peptídeos identificados, finalizamos a caracterização do FTR, um tripeptídeo que apresentou em nossos trabalhos anteriores propriedades antinociceptivas. No presente trabalho, demonstramos que este peptídeo é capaz de agir na via opioide, atuando em receptores delta de forma direta. Assim, com a identificação e caracterização destas moléculas conseguimos novos dados referentes a possíveis origens e processamento, ações tóxicas no envenenamento e potencial biotecnológico de alguns peptídeos lineares do T. serrulatus. / Reports of scorpions accidents with humans are increasing in Brazil, with some of the cases resulting in death. Among the scorpions from the Brazilian fauna, Tityus serrulatus is considered the most dangerous species, due to its easy adaptation in urban centers, and because it brings severe clinical manifestations in the victims, such as fever, psychomotor agitation, arterial hypertension followed by hypotension and acute pulmonary edema. Among the venom components that stand out are the peptides structured by disulfide bonds, which are richly reported in the literature and act on Na+ and K+ channels. In contrast, linear peptides are poorly characterized. From this evidence, our group identified linear peptides of the venom using the serine protease elastase screening. This enzyme was chosen because it is involved in inflammatory processes, such as cases of acute pulmonary edema, one of the main symptoms of scorpionism caused by T. serrulatus. More than 700 peptide sequences where found and, through a careful process using protein databases and the literature, from these all, we selected nine novel (TsP1 to TsP9) and two already characterized (hypotensins I and II) sequences for synthesis. Among these molecules, we identified possible cryptides derived from Ts19 and others molecules, with different processing involving combination of different peptide sequences (chimeric peptides), which are here firstly reported and investigated in the venom of T. serrulatus. In addition to elastase, we tested other enzymes of medical importance - trypsin, ACE and NEP - with the synthetic peptides, aiming to increase the knowledge of molecular mechanisms involved in scorpionism and also based on the biotechnological potential of peptidase-modulator molecules. Peptides that may have an action in inflammatory processes were highlighted, since they were able to increase the activity of elastase and trypsin, especially the TsP5, which also showed intermediate cytotoxicity. Some peptides increased the ACE activity, with the peptide TsP2 capable of potentializing the action of bradykinin in vivo. Hypotensin I was characterized as a noncompetitive inhibitor of NEP (Ki = 4.35 µM) and may indicate the possible inhibition of this metallopeptidase in cases of hypotension, where hypotensin I may act synergistically with [des-Arg1] - Proctolin (Kµ = 0.94 µM for NEP), a linear peptide present in the venom already characterized by our group. The peptides were not recognized by the antiscorpion and antiarachinid sera produced by the Butantan Institute and may indicate limitations in the immunotherapy. Finally, in addition to the new identified peptides, we concluded the in vivo characterization of FTR, a tripeptide that presented antinociceptive properties in our previous studies. In the present work, we demonstrate that this peptide is able to act in the opioid pathway, acting directly on delta receptors. Thus, with the identification and characterization of these molecules we obtained new data regarding possible origins and processing, toxic actions in the envenomation and biotechnological potential of some linear peptides of T. serrulatus venom.

Foi observado no Laboratório de Herpetologia do Instituto Butantan que indivíduos da espécie Bothrops moojeni, quando acidentados entre si, apresentavam casos de mortalidade ocasionados por efeitos do envenenamento. Um modelo composto de análises bioquímicas e biológicas de 13 amostras de veneno e plasma de serpentes B. moojeni foi utilizado. SDS-PAGE mostrou perfis proteicos bem distintos para as amostras de veneno, e não para as de plasma. Western Blottings (WB) com amostras desses plasmas mostraram uma zona de detecção na faixa de 25 kDa em alguns indivíduos. Outro teste de WB, cruzando amostras de plasmas e venenos, mostrou que alguns indivíduos possuem proteínas que se ligam à estas regiões do plasma, o que não ocorre com o veneno dos outros indivíduos testados. Espectrometria de massas mostrou que esses indivíduos apresentam maiores concentrações proteicas e outras tantas exclusivas, incluindo inibidores de fosfolipases. A Dose Letal 50% mostrou uma maior eficiência nesses venenos, enquanto que a Dose Mínima Hemorrágica se mostrou inferior. Conclui-se que alguns indivíduos dessa espécie apresentam diferenças na composição dos seus venenos que se tornam significativas para o envenenamento. / It was observed in the Herpetology Laboratory of the Butantan Institute that individuals of the species Bothrops moojeni, when injured among themselves, presented cases of mortality caused by the effects of envenoming. A model composed of biochemical and biological analyzes of 13 venom and plasma samples of B. moojeni snakes was used. SDS-PAGE showed very different protein profiles for the venom samples, and not for the plasma ones. Western Blottings (WB) with samples of these plasmas showed a detection zone in the range of 25 kDa in some individuals. Another WB test, cross-linking plasma and venom samples, showed that some individuals have proteins that bind to these regions of the plasma, which does not occur with the venom of the other individuals tested. Mass spectrometry results showed that these individuals have higher protein and other unique concentrations, including phospholipase inhibitors. The Lethal Dose 50% showed a higher efficiency in these venoms, whereas the Minimum Hemorrhagic Dose was inferior. It is concluded that some individuals of this species present differences in the composition of their poisons that become significant for the envenoming process.